Cbd Life Sciences Stock Last Dividend Paid
| CBDL Stock | USD 0.0005 0.0001 25.00% |
Cbd Life Sciences fundamentals help investors to digest information that contributes to Cbd Life's financial success or failures. It also enables traders to predict the movement of Cbd Pink Sheet. The fundamental analysis module provides a way to measure Cbd Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cbd Life pink sheet.
Cbd |
Cbd Life Sciences Company Last Dividend Paid Analysis
Cbd Life's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Cbd Life Sciences has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Cbd Fundamentals
| Return On Equity | -3.89 | |||
| Return On Asset | 0.0025 | |||
| Operating Margin | (23.29) % | |||
| Current Valuation | 51.93 K | |||
| Shares Outstanding | 3.58 K | |||
| Price To Sales | 0.26 X | |||
| Revenue | 138.19 K | |||
| Gross Profit | 27.43 K | |||
| EBITDA | (608.24 K) | |||
| Net Income | (6.14 M) | |||
| Cash And Equivalents | 303.09 K | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 1.43 X | |||
| Cash Flow From Operations | (6.29 M) | |||
| Beta | 48.75 | |||
| Market Capitalization | 35.85 K |
About Cbd Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cbd Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cbd Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cbd Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cbd Pink Sheet
Cbd Life financial ratios help investors to determine whether Cbd Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cbd with respect to the benefits of owning Cbd Life security.